AU2264697A - Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound - Google Patents

Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound

Info

Publication number
AU2264697A
AU2264697A AU22646/97A AU2264697A AU2264697A AU 2264697 A AU2264697 A AU 2264697A AU 22646/97 A AU22646/97 A AU 22646/97A AU 2264697 A AU2264697 A AU 2264697A AU 2264697 A AU2264697 A AU 2264697A
Authority
AU
Australia
Prior art keywords
compound
hexahydro
morpholine
compositions containing
therapeutic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22646/97A
Inventor
Edward James Carlin
Anil Kumar Talwar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU2264697A publication Critical patent/AU2264697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU22646/97A 1996-02-09 1997-02-07 Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound Abandoned AU2264697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1148396P 1996-02-09 1996-02-09
US011483 1996-02-09
PCT/US1997/002028 WO1997028805A1 (en) 1996-02-09 1997-02-07 Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound

Publications (1)

Publication Number Publication Date
AU2264697A true AU2264697A (en) 1997-08-28

Family

ID=21750589

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22646/97A Abandoned AU2264697A (en) 1996-02-09 1997-02-07 Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound

Country Status (2)

Country Link
AU (1) AU2264697A (en)
WO (1) WO1997028805A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248309B1 (en) * 1997-04-04 2001-06-19 Optiva Corporation Gums containing antimicrobial agents
WO2005097094A1 (en) * 2004-04-08 2005-10-20 Dermcare-Vet Pty Ltd Antimicrobial compositions and methods for their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870151A (en) * 1959-01-20 Mqrpholine -ethers
US3836654A (en) * 1973-04-12 1974-09-17 Commercial Solvents Corp Composition containing hexetidine and 2-methyl-2-nitro-1,3-dimorpholinopropane

Also Published As

Publication number Publication date
WO1997028805A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
AU6513298A (en) Therapeutic compositions
AU7842794A (en) Oral compositions
AU4016095A (en) Oral compositions
AU5804194A (en) Oral compositions
AU5136998A (en) Medicinal composition
AU3650895A (en) Oral compositions
AUPN411195A0 (en) Medicinal composition
AU2372095A (en) Oral compositions
AU2223495A (en) Spiro compound and medicinal composition thereof
AU6776494A (en) Oral compositions
AU3308195A (en) Antihypertriglyceridemic composition
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU4425696A (en) Polymerizable compounds and compositions
AU2531295A (en) Pharmaceutical composition
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU7345094A (en) Oral compositions
AU2427895A (en) Oral compositions
AU3460897A (en) Medicinal compositions
AU3942197A (en) A glasswashing composition
AU5512694A (en) Oral composition
AUPN727595A0 (en) Therapeutic compositions
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU2264697A (en) Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound
AU7641098A (en) Therapeutic composition
AU7190496A (en) Therapeutic compositions